Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Amortizatization of Intangibles: 2020-2025

Historic Amortizatization of Intangibles for Foghorn Therapeutics (FHTX) over the last 5 years, with Sep 2025 value amounting to $356,000.

  • Foghorn Therapeutics' Amortizatization of Intangibles fell 80.06% to $356,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 9.89%. This contributed to the annual value of $4.6 million for FY2024, which is 74.01% up from last year.
  • Per Foghorn Therapeutics' latest filing, its Amortizatization of Intangibles stood at $356,000 for Q3 2025, which was down 20.18% from $446,000 recorded in Q2 2025.
  • In the past 5 years, Foghorn Therapeutics' Amortizatization of Intangibles registered a high of $1.8 million during Q3 2024, and its lowest value of -$100,000 during Q3 2021.
  • In the last 3 years, Foghorn Therapeutics' Amortizatization of Intangibles had a median value of $705,000 in 2024 and averaged $807,636.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first tumbled by 9,800.00% in 2021, then surged by 6,540.00% in 2022.
  • Foghorn Therapeutics' Amortizatization of Intangibles (Quarterly) stood at -$97,000 in 2021, then spiked by 691.75% to $574,000 in 2022, then dropped by 13.76% to $495,000 in 2023, then skyrocketed by 216.97% to $1.6 million in 2024, then plummeted by 80.06% to $356,000 in 2025.
  • Its last three reported values are $356,000 in Q3 2025, $446,000 for Q2 2025, and $818,000 during Q1 2025.